Amecath is an Egypt-based medical device manufacturer with a focus on catheters. Established in 1991, it is the leading catheter manufacturing company in Egypt and offers a high quality/low cost, differentiated and intellectual property (IP) protected (for several key products) catheter product range, with potential for significant growth through further development of product intellectual property and new growth markets.
The company currently holds five FDA approved products, and exports to more than 55 markets, and consistently increases its research and development activities to develop further intellectual property in its product range across dialysis, urology and central venous catheters. New product ranges were introduced recently, comprising percutaneous sheath introducers and diagnostic catheters. Currently the company is preparing a strong push into US and European markets which will be the main driver of growth in the next years.
E&S Performance – Community Engagement
Amecath employs 400 people in total, of which 303 are male and 94 are female. 9.6% of management positions are held by women. The majority of the workforce (397 people) are Egyptian, with 2 employees from Syria and 1 from Jordan. Nine audits covering labour issues were conducted in 2017; five by the Egypt Social Security Office, and four by the Labour Office. No significant issues were identified.
Decrease in plastic waste by 9% from 2016, Electricity consumption decreased by 2% from 2016 Water consumption decreased by 64% from 2016.
Amecath has established a three year “Brotherhood agreement” with Abo Twala village, the village where most of their employees are from. As part of this agreement, Amecath employees run social projects in the village, such as building a public library and running environmental “clean-up days”. In 2017, Amecath donated 10,000 person-hours of pro bono volunteer time to these projects.